Table of contents
May 2008 Volume 5 No 5
Viewpoints
Should men over the age of 65 years receive PSA screening? Argument in favor
230Whether or not men over the age of 65 years should receive PSA screening for prostate cancer is a controversial issue. In this first of two Viewpoints on the topic, Whitson and Konety argue that men over 65 years old can have clinically relevant prostate cancer, that they can benefit from prostate cancer treatment, and that PSA screening is warranted in these men.
doi:10.1038/ncpuro1078 | Full Text | PDF (103K)
Should men over the age of 65 years receive PSA screening? Argument against
232In this second Viewpoint on PSA testing in men over 65 years of age, Albertsen argues that, from a public health perspective, PSA screening should not be performed in these men. The author discusses the health problem of prostate cancer in this patient population, the accuracy of the PSA test, patient outcomes, and the harm associated with PSA testing.
Research Highlights
Laser excision is effective for treating early-stage penile carcinoma
234Association between stroke lesions and sexual dysfunction in men
234Varicocele: good results for transcatheter foam sclerotherapy
234Long-term results of bladder augmentation with de-epithelialized intestine
235Beneficial effect of vardenafil on LUTS secondary to BPH
235Prompt initiation of pharmacotherapy benefits patients with interstitial cystitis
236Personalized medicine for men with benign prostatic hyperplasia
236Clinical value of ultrasonography in diagnosis of renal tuberculosis
237Finasteride chemoprevention might be cost-effective in high-risk populations
237Advanced prostate cancer can be predicted by PSA level measured up to 25 years earlier
238Validation of the Partin Tables for staging prostate cancer in African American men
238Risk of prostate cancer is not affected by prediagnosis sex-hormone levels
238Reduced likelihood of RCC in patients taking statins
239Practice Points
Is there a relationship between urinary tract infection, vesicoureteral reflux and renal damage in children?
240doi:10.1038/ncpuro1095 | Full Text | PDF (100K)
What is the relationship between the transobturator tape procedure and urethral mobility in women with SUI?
242doi:10.1038/ncpuro1096 | Full Text | PDF (100K)
Is robotically assisted laparoscopic pyeloplasty effective for the treatment of pelvi-ureteric junction obstruction?
244doi:10.1038/ncpuro1054 | Full Text | PDF (101K)
Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?
246Should incidental inguinal hernias be repaired with prosthetic mesh during RALP?
248doi:10.1038/ncpuro1098 | Full Text | PDF (100K)
Does tertiary Gleason score 5 have prognostic significance in men with prostate cancer?
250doi:10.1038/ncpuro1099 | Full Text | PDF (100K)
Reviews
Management of boys with nonpalpable undescended testis
252During the past 15 years, there has been extensive international research in boys with nonpalpable testis. However, the question of what the gold-standard treatment for this disorder should be still remains. This Review assesses the current data on this disorder.
doi:10.1038/ncpuro1102 | Full Text | PDF (182K)
Management of advanced germ-cell tumors of the testis
262The incidence of germ-cell tumors in men is increasing in Western countries for reasons that are still unknown; however, these tumors are very curable. In this Review, the authors summarize the classification of germ-cell tumors, as well as the treatment options that are available.
doi:10.1038/ncpuro1101 | Full Text | PDF (222K)
Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
277Overtreatment of any disease should be avoided, but the best way to achieve this goal is not always clear. Dall'Era and Konety review active surveillance as an option for men at low risk of developing prostate cancer. They discuss recently reported experiences, modern monitoring methods and the psychosocial impact of this approach.
doi:10.1038/ncpuro1058 | Full Text | PDF (137K)
Case Study
Contralateral intratubular germ cell neoplasia in a patient with testicular cancer
284In this Case Study, Buchler et al. report the case of 27-year-old man who had undergone right orchiectomy for testicular seminoma and was subsequently diagnosed with intratubular germ cell neoplasia of the contralateral, atrophic, testis. The controversial issue of testicular biopsy is discussed, as is the optimum management approach in the context of fertility therapy.
doi:10.1038/ncpuro1100 | Full Text | PDF (275K)
